Kane Biotech (KNE) News Today C$0.10 +0.01 (+5.26%) As of 02/21/2025 10:06 AM Eastern Add Compare Share Share Headlines Stock AnalysisChartEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Kane Biotech Inc. (CVE:KNE) Director Marc Edwards Purchases 2,000,000 SharesJanuary 24, 2025 | insidertrades.comKane to Host Investor Webinar – What Kane has in Store for 2025 Including the Acquisition of FB DermatologyJanuary 21, 2025 | finance.yahoo.comKane Biotech Unveils 2025 Strategy and Marketing PushJanuary 21, 2025 | tipranks.comOilers’ Evander Kane undergoes knee surgery, recovery timeline is 4-8 weeksJanuary 10, 2025 | msn.comKane Biotech Inc KNEDecember 27, 2024 | morningstar.comKane Biotech Announces Change in US Distribution Partner for revyve(TM) Antimicrobial Wound GelNovember 28, 2024 | stockhouse.comKane Biotech Announces Health Canada Approval of revyve™ Antimicrobial Wound GelNovember 14, 2024 | markets.businessinsider.comKane Biotech Provides Investor Update Following FB Dermatology Acquisition AnnouncementNovember 14, 2024 | markets.businessinsider.comKane Biotech Announces Agreement to Acquire FB DermatologyNovember 12, 2024 | markets.businessinsider.comKane Biotech Announces Donation of revyve™ Antimicrobial Wound Gel to UkraineOctober 23, 2024 | markets.businessinsider.comPositive Signs As Multiple Insiders Buy Kane Biotech StockOctober 21, 2024 | finance.yahoo.comKane Biotech to distribute XSONX Wound Hygiene SystemOctober 19, 2024 | msn.comKane Biotech Announces Exclusive Distribution Agreement With XSONXOctober 17, 2024 | finance.yahoo.com'Positive development' - Harry Kane has no serious injurySeptember 30, 2024 | sports.yahoo.comKane Biotech Announces Attendance at Upcoming Wound Care ConferencesSeptember 26, 2024 | finance.yahoo.comKane Biotech Inc. (CVE:KNE) Director Buys C$11,250.00 in StockSeptember 18, 2024 | insidertrades.comKane Biotech Inc.September 17, 2024 | wsj.comKane Biotech Announces Exercise of WarrantsSeptember 12, 2024 | markets.businessinsider.comKane Biotech Inc.: Kane Biotech Announces Second Quarter 2024 Financial ResultsAugust 30, 2024 | finanznachrichten.deKane Biotech Announces new DispersinB® Publication in Pathogens and Conference PresentationsAugust 30, 2024 | tmcnet.comKane Biotech Announces Second Quarter 2024 Financial ResultsAugust 30, 2024 | markets.businessinsider.comKane Biotech Announces Distribution Agreement with Qatar Datamation Systems for revyve™ Antimicrobial Wound GelAugust 28, 2024 | finance.yahoo.comKane Biotech Announces Distribution Agreement with Razan Medical Trading for revyve(TM) Antimicrobial Wound GelAugust 24, 2024 | stockhouse.comKane Biotech Announces Distribution Agreement with Razan Medical Trading for revyve™ Antimicrobial Wound GelAugust 22, 2024 | finance.yahoo.comStocks in play: Talisker Resources Ltd.August 14, 2024 | ca.finance.yahoo.comKane Returns as Tottenham Clash with Bayern Munich In PreseasonAugust 9, 2024 | sports.yahoo.comInsider Buying: Kane Biotech Inc. (CVE:KNE) Director Buys 150,000 Shares of StockJuly 30, 2024 | insidertrades.comKane Biotech Inc.: Kane Biotech Receives FDA Approval to Increase Dosage Allowance of its revyve Antimicrobial Wound GelJuly 23, 2024 | finanznachrichten.deKane Biotech Receives FDA Approval to Increase Dosage Allowance of its revyve™ Antimicrobial Wound GelJuly 23, 2024 | finance.yahoo.comKane Biotech Receives ISO 13485:2016 MDSAP Quality CertificationJuly 19, 2024 | finance.yahoo.comKane Biotech Inc. (CVE:KNE) Director Purchases C$48,300.00 in StockJune 26, 2024 | insidertrades.comPatrick Kane is King William High's new athletics directorMay 28, 2024 | yahoo.comKane Biotech Inc.: Kane Biotech Announces First Quarter 2024 Financial ResultsMay 24, 2024 | finanznachrichten.deKane Biotech Announces First Quarter 2024 Financial ResultsMay 23, 2024 | finance.yahoo.comKane Biotech Expands its Wound Care Portfolio with Patented Schultz Biofilm Wound MapMay 15, 2024 | finance.yahoo.comHarry Kane on target but Vinicius Jr brace earns Real Madrid first-leg drawApril 30, 2024 | msn.comKane double steers Bayern 2-1 past Frankfurt ahead of Real clashApril 28, 2024 | reuters.comKane sets personal record with double in Bayern winApril 27, 2024 | msn.comKane Biotech Inc. (CVE:KNE) Director Sells C$260,000.00 in StockApril 23, 2024 | insidertrades.comKane Biotech Inc.: Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary ProductsApril 16, 2024 | finanznachrichten.deKane Biotech to Host Investor WebinarApril 16, 2024 | tmcnet.comDual Listed Biotech Firm Achieves Sale of Animal Health Interest, Sending Shares HigherApril 15, 2024 | msn.comKane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary ProductsApril 15, 2024 | stockhouse.com'Light Injuries': Harry Kane's Children In Munich Car AccidentApril 12, 2024 | barrons.comKane Biotech Inc.: Kane Biotech Announces Agreement in Principle for the Sale of its Interest in STEM Animal HealthApril 11, 2024 | finanznachrichten.deCanadian Investment Regulatory Organization Trading Halt - KNEApril 11, 2024 | ca.finance.yahoo.comCanadian Investment Regulatory Organization Trade Resumption - KNEApril 11, 2024 | finance.yahoo.comKane Biotech Inc.: Kane Biotech Announces Fourth Quarter and Full Year 2023 Financial ResultsMarch 29, 2024 | finanznachrichten.deKane Biotech Announces Fourth Quarter and Full Year 2023 Financial ResultsMarch 27, 2024 | finance.yahoo.comKane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal HealthMarch 20, 2024 | finance.yahoo.com Get Kane Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KNE and its competitors with MarketBeat's FREE daily newsletter. Email Address KNE Media Mentions By Week KNE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KNE News Sentiment▼0.000.60▲Average Medical News Sentiment KNE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KNE Articles This Week▼01▲KNE Articles Average Week Get Kane Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KNE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Devonian Health Group News Hemostemix News Sirona Biochem News Aptose Biosciences News Innovotech News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:KNE) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kane Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kane Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
